Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
Elizabeth R. Hayden, Mingqing Chen, Kyle Z. Pasquariello, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 15, pp. 4301-4310
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Membrane transporters in drug development and as determinants of precision medicine
Aleksandra Galetin, Kim L. R. Brouwer, Donald Tweedie, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 255-280
Closed Access | Times Cited: 93
Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium
Kim L. R. Brouwer, Raymond Evers, Elizabeth R. Hayden, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 3, pp. 461-484
Open Access | Times Cited: 46
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Elena Puris, Gert Fricker, Mikko Gynther
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 364-364
Open Access | Times Cited: 32
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108459-108459
Closed Access | Times Cited: 30
Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies
Piotr Chodup, Sophia L. Samodelov, Michele Visentin, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access | Times Cited: 1
PharmVar GeneFocus: SLCO1B1
Laura B. Ramsey, Li Gong, Seung‐been Lee, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 4, pp. 782-793
Open Access | Times Cited: 38
Transcriptional Regulation of Solute Carrier Drug Transporters
Shiwei Zhou, Yan Shu
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 9, pp. 1238-1250
Open Access | Times Cited: 26
High‐dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study
Xiaoxiao Chen, Jing Li, Liting Yu, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1354-1366
Closed Access | Times Cited: 3
Coproporphyrin I as an in vitro fluorescent probe to measure OATP1B1 transport activity.
Elizabeth R. Hayden, Vivian Xu, Lisa Krotz, et al.
Drug Metabolism and Disposition (2025) Vol. 53, Iss. 5, pp. 100073-100073
Closed Access
Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors
Chitra Saran, Louise Sundqvist, Henry Ho, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 380, Iss. 2, pp. 114-125
Open Access | Times Cited: 21
Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation
Anne T. Nies, Elke Schaeffeler, Matthias Schwab
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108268-108268
Closed Access | Times Cited: 16
Progress in the Quantitative Assessment of Transporter-Mediated Drug–Drug Interactions Using Endogenous Substrates in Clinical Studies
Tatsuki Mochizuki, Hiroyuki Kusuhara
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 9, pp. 1105-1113
Open Access | Times Cited: 8
Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy
Yang Li, Thomas Drabison, Mahesh R. Nepal, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 7
High-quality and robust protein quantification in large clinical/pharmaceutical cohorts with IonStar proteomics investigation
Shichen Shen, Xue Wang, Xiaoyu Zhu, et al.
Nature Protocols (2022) Vol. 18, Iss. 3, pp. 700-731
Open Access | Times Cited: 11
Mass spectrometry analysis of phosphotyrosine‐containing proteins
Jiajia Li, Xianquan Zhan
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 4, pp. 857-887
Closed Access | Times Cited: 4
Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins
John T. Powell, Ruhul Kayesh, Alexandra Ballesteros-Perez, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 63-63
Open Access | Times Cited: 4
Organic anion transporting polypeptides (OATPs/SLCOs): Pharmacology, toxicology, structure, and transport mechanisms
Bruno Hagenbuch, Bruno Stieger, Kaspar P. Locher
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100023-100023
Closed Access | Times Cited: 1
Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing
Manuel Ibarra, Ryan Combs, Zachary L. Taylor, et al.
British Journal of Clinical Pharmacology (2022) Vol. 89, Iss. 2, pp. 660-671
Closed Access | Times Cited: 7
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen
Thomas Drabison, Mike Boeckman, Yan Yang, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 9, pp. 2489-2497
Open Access | Times Cited: 1
Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake
Vusumuzi N. Hove, Kenneth C. Anderson, Elizabeth R. Hayden, et al.
Molecular Pharmacology (2022) Vol. 101, Iss. 6, pp. 381-389
Open Access | Times Cited: 6
Effect of mTOR inhibitors on sodium taurocholate cotransporting polypeptide (NTCP) function in vitro
Chitra Saran, Henry Ho, Paavo Honkakoski, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B
Dominique A. Garrison, Yan Jin, Zahra Talebi, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 6815-6815
Open Access | Times Cited: 5
Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors
Elodie Jouan, A Moreau, Arnaud Bruyère, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2021) Vol. 46, Iss. 5, pp. 625-635
Open Access | Times Cited: 7
Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters
Xuyang Wang, Mei Hong
Molecular Pharmacology (2022) Vol. 103, Iss. 1, pp. 9-20
Open Access | Times Cited: 4
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?
Kshitee Kharve, Andrew S. Engley, Mary F. Paine, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 447-447
Open Access
Page 1 - Next Page

Scroll to top